Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06938230 · ClinicalTrials.gov registry record · NA

Coronavirus Disease of 2019 (COVID-19) Health Education Initiative for School Safety

A NA study of COVID-19, sponsored by University of Miami.

Completed
Registry status
NA
Development phase
112
Enrollment target
1
Study location

NCT06938230: Completed NA study of COVID-19, sponsored by University of Miami.

NCT06938230 is a NA study of COVID-19 that has completed, run by University of Miami. The registered enrollment target is 112 participants, below the 38,465-participant average among 298 other COVID-19 trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06938230, a NA study of COVID-19, has completed, sponsored by University of Miami.

COMPLETED
Registry status
NA
Development phase
112 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to compare COVID-19 knowledge, experiences, and health behaviors between participants who received the health initiative and those who did not.

Primary Outcome

Scores range from 1 ("strongly disagree") to 5 ("strongly agree"), with higher scores indicating more knowledge, value, application, or satisfaction. Evaluation was collected directly after the intervention, at baseline.

Conditions Studied

Interventions

  • BEHAVIORAL Health Education Initiative

Study Locations (1)

Florida

  • University of Miami - Miami

Trial Details

FieldValue
Enrollment Target 112 participants
Start Date 2022-08-02
Est. Completion 2023-06-10
Phase NA
University of Miami

721 total trials

What the finished NCT06938230 record still lists

NCT06938230 is an interventional study that assigns participants to a tested intervention. The registered 112 participants enrollment target is mid-sized for trials with a published cap, below the 38,465-participant average among 298 other COVID-19 trials with a reported enrollment target (100% lower).

The record links to 1 condition, with COVID-19 appearing as the primary indexed condition, and to 1 intervention - of which Health Education Initiative is the first listed.

NCT06938230 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT06938230 about?

NCT06938230 is a clinical study titled "Coronavirus Disease of 2019 (COVID-19) Health Education Initiative for School Safety". The purpose of this study is to compare COVID-19 knowledge, experiences, and health behaviors between participants who received the health initiative and those who did not.

What is the current status of trial NCT06938230?

This trial is currently completed. It is a NA study. The enrollment target is 112 participants. The study started on 2022-08-02. Estimated completion is 2023-06-10.

What conditions does trial NCT06938230 study?

This clinical trial studies the following conditions: COVID-19.

What interventions are being tested in trial NCT06938230?

The interventions under investigation include: Health Education Initiative (BEHAVIORAL).

Who is sponsoring clinical trial NCT06938230?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06938230 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for COVID-19

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06938230's enrollment target sits among peer trials

112 191st of 298 higher than 106 of 298 other COVID-19 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other COVID-19 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04511013 · 112 participants · Phase 2

    A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

  • NCT04551560 · 112 participants · NA

    Stress and Congestive Heart Failure

  • NCT04872166 · 112 participants · Phase 1

    A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer

  • NCT05024773 · 112 participants · Phase 3

    Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06938230, the US trial registry maintained by the National Library of Medicine. NCT06938230 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.